Navigation Links
Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
Date:7/24/2012

clinical development and could fail at any time due to numerous unpredictable and significant risks related to safety, efficacy and other important findings that can negatively impact clinical development; (iv) the U.S. Food and Drug Administration and other health authorities could impose significant risk mitigation requirements that hamper the commercial potential of NKTR-181, even if this drug candidate receives regulatory approval; (v) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platform to potential new drug candidates such as NKTR-181 is therefore very uncertain and unpredictable and could unexpectedly fail at any time; (vi) patents may not issue from our patent applications for NKTR-181, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vii) the outcome of any existing or future intellectual property or other litigation related to our proprietary drug candidates.  Other important risks and uncertainties are detailed in our reports and other filings with the Securities and Exchange Commission ("SEC"), including without limitation, those risks and uncertainties set forth in our Form 10-Q for the quarter ended March 31, 2012, filed with the SEC on May 4, 2012. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics

(415) 482-5585Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... LA HABRA, Calif. , May 1, 2015 /PRNewswire-USNewswire/ ... to announce its 2015 health literacy award winners. The ... reward initiatives that make an impact on the practice ... that advance health literacy. IHA gives awards in three ... IHA also bestowed its Health Literacy Hero award. ...
(Date:5/1/2015)... 1, 2015 Semler Scientific, Inc. (Nasdaq: ... develops, manufactures and markets products that assist healthcare providers ... financial results for the first quarter ended March 31, ... 2015, Semler reported continued progress with year over year ... growth of 14%," said Doug Murphy-Chutorian , M.D., ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... 12, 2011 Reportlinker.com announces that a new ... Global Injectable Drug Delivery Market ... Report Description : ... * To define and measure the Injectable drug ...
... BOSTON, Oct. 12, 2011 PAREXEL International Corporation ... biopharmaceutical services provider, today announced that it has ... topics throughout the clinical development and commercialization lifecycle. ... are conversations with thought leaders from PAREXEL designed ...
Cached Medicine Technology:Global Injectable Drug Delivery Market (2010 - 2015) 2Global Injectable Drug Delivery Market (2010 - 2015) 3Global Injectable Drug Delivery Market (2010 - 2015) 4Global Injectable Drug Delivery Market (2010 - 2015) 5Global Injectable Drug Delivery Market (2010 - 2015) 6Global Injectable Drug Delivery Market (2010 - 2015) 7Global Injectable Drug Delivery Market (2010 - 2015) 8Global Injectable Drug Delivery Market (2010 - 2015) 9Global Injectable Drug Delivery Market (2010 - 2015) 10Global Injectable Drug Delivery Market (2010 - 2015) 11Global Injectable Drug Delivery Market (2010 - 2015) 12New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 2New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 3New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 4
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... 2015 SpineFrontier, a Less Exposure Surgery ... to produce and market their new sacroiliac joint fusion ... in outpatient settings and is compatible with both lateral ... has been extensively researched and refined by SpineFrontier, the ... this approach in conjunction with a sacroiliac joint fusion ...
(Date:5/3/2015)... 2015 HealthPostures, a pioneering ergonomics ... its appearance at the , May 5 - 7, ... will exhibit at the conference include its bestselling TaskMate ... solutions is the 6100 TaskMate Executive. Features of the ... adjustable keyboard tray, extended platform work surface and supply ...
(Date:5/2/2015)... NV (PRWEB) May 02, 2015 Ticket Down ... tickets for the long awaited event today, Saturday, May ... Diehard boxing fans will be able to secure tickets ... , The fight that boxing fans have wanted for more ... months ago. Floyd “Money” Mayweather will step inside the ring ...
(Date:5/2/2015)... ActOn ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers how this app ... difference. , In this material world, almost everything is about ... which is why those things should be prioritized above others. ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... who were treated with anti-tumor necrosis factor alpha, ... exacerbations than individuals taking a placebo. ,This ... 2006 of the American Journal of Respiratory and ... Society. ,Trevor T. Hansel, M.D., Ph.D., ...
... care in United Kingdom, and a munificent grant of ?45 ... figure anywhere on the NHS dental list. , ,The ... NHS registrations, down by a 42000 enrollments. This, notwithstanding the ... to ensure registrations are maintained. Yet, it has not made ...
... professor says that laws, which require minors to seek ... sexual behavior// in this segment of the society. Jonathan ... Thomas Stratmann, professor of economics at George Mason University ... laws seeking parental consent may play an important role. ...
... developed a prototype bandage that could detect hidden fractures once ... by Ozan Akkus and colleagues at Purdue University in Indiana ... created by tiny cracks in damaged bones, reported the online ... alarm, warning the patient to rest so that the injured ...
... capital has recorded 327 cases of dengue fever this year so ... ,According to health authorities here, two more people have died ... nine. ,Out of the 327 cases reported, 127 cases ... that the next two months is likely to see a surge ...
... The directory of patented drugs will play host to a ... to the recent communique // by the Director of patent ... in the arm for the multitude of generic drug manufacturers, ... the drug to developing nations. ,Biolyse ...
Cached Medicine News:Health News:Monoclonal Antibody Reduces Exacerbations in Asthmatics 2Health News:Laws That Make Parental Consent Mandatory Reduce Risky Sexual Behavior 2
8 mm S Graftech cervical spacer....
... system for procedures in the ... system features a broad selection ... for many Craniomaxillofacial procedures. 1.5 ... used predominately in the less ...
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
... Timesh 1.5 Titanium Cranial Fixation Systems ... benefits specifically requested by surgeons and ... cranioplasty implants may be either shaped ... procedure warrants, a pre-measured, cut, bent ...
Medicine Products: